TITLE

GERMAN REGULATORY AUTHORITY COMPLETES INSPECTION OF ATRIX

PUB. DATE
July 2003
SOURCE
Worldwide Biotech;Jul2003, Vol. 15 Issue 7, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Deals with the completion of the inspection for the manufacturing facility of Atrix Laboratories Inc. by the German regulatory authority, Bundesinstitut fur Arzneimittel und Medizinprodukte in Germany.
ACCESSION #
10170080

 

Related Articles

  • MARKET BRIEFS.  // Chemical Market Reporter;4/2/2001, Vol. 259 Issue 14, p14 

    Presents news briefs on the pharmaceutical industry in Europe as of August 2, 2001. Recommendation for the market approval of Replagal, an enzyme replacement therapy; Drug application submitted by Atrix Laboratories Inc. for Leuprogel, a sustained release product for the treatment of advanced...

  • Active Pharmaceutical Ingredient Watch.  // Chemical Market Reporter;6/3/2002, Vol. 261 Issue 22, p12 

    Presents an update on the pharmaceutical industry in the U.S. as of June 3, 2002. Launch of the cancer drug Eligard 7.5 milligram by Atrix Laboratories Inc.; Deal between Biovail Corp. and DepoMed Inc.; Approval of the Ebixa drug from Neurobiological Technologies Inc.

  • INDUSTRY REPORT.  // Drug Discovery & Development;Feb2002, Vol. 5 Issue 2, p27 

    Reports developments related to the pharmaceutical industry as of February 2002. Establishment of Agro-LEADS, a subsidiary of Compugen Ltd.; Approval for the drug Eligard, developed by Atrix Laboratories Inc.; Collaboration between Curis Inc. and AGY Therapeutics Inc.

  • Pharma in Brief.  // Chemical Market Reporter;3/1/2004, Vol. 265 Issue 9, p7 

    Presents news briefs related to the drug industry compiled as of March 1, 2004. Aldolor Corp. and GlaxoSmithKline PLC's receipt of fast track status for the drug Entereg under development for the management of postoperative ileus; U.S. Food & Drug Administration's granting of priority review...

  • pharmaceuticals In Brief.  // Chemical Market Reporter;3/8/2004, Vol. 265 Issue 10, p8 

    Reports on developments concerning the pharmaceutical industry as of March 8, 2004. Approval granted by the Canadian pharmaceutical authorities for Atrix Laboratories Inc.'s Eligard, a four-month sustained-release prostate-cancer product; Expansion of the agreement between Bayer Pharmaceuticals...

  • PHARMA & FINE CHEMICALS: Market Briefs.  // Chemical Market Reporter;04/19/99, Vol. 255 Issue 16, p22 

    Presents market updates on pharmaceutical and fine chemical industry in the United States as of April 1999. Development of Virulizin drug by Lorus Therapeutics Inc. for pancreatic cancer; Information on the Eucalyptamint 2000 arthritis pain relieving gel from Atrix Laboratories Inc.; Details on...

  • NEWS IN BRIEF.  // European Chemical News;1/20/2003, Vol. 78 Issue 2036, p24 

    Presents news briefs on the pharmaceutical industry as of January 2003. Purpose of the licensing agreement signed by GTC Biotherapeutics and Trans Ova Genetics; Agreement reached between Atrix Laboratories and Sosei; Schedule of the trial over U.S. patents on GlaxoSmithKline's anti-depressant...

  • Atrix Laboratories, Inc. SWOT Analysis.  // Atrix Laboratories, Inc. SWOT Analysis;October 2003, p1 

    Presents an overview of Atrix Laboratories Inc., which is a specialty pharmaceutical company focused on advanced drug delivery and product development. Company overview, including revenues generated in fiscal year 2002, services provided, and principal businesses; Key facts, including contact...

  • Company Overview.  // Atrix Laboratories, Inc. SWOT Analysis;October 2003, p4 

    Presents an overview of Atrix Laboratories Inc., which is a specialty pharmaceutical company focused on advanced drug delivery and product development. Revenues generated in fiscal year 2002; Principal business offered, including advanced drug delivery and product development.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics